SB

Suraj Babruwahan Ronge

Active Director Director DIN 06685060
DIN 06685060 First appointment Mar 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Mar 2018
Shareholding value •••• Premium profile

About Suraj Babruwahan Ronge

Data last updated:

Suraj Babruwahan Ronge is a Director at Rsense Healthcare Private Limited (since 2020), Director at Rsense Technology Solutions Private Limited (since 2018) and Director at Acic - Sveri Pandharpur Arise Foundation (since 2022). The companies operate in Healthcare, Information Technology and Non-Profit Organizations. The 3 current companies with reported revenue have a combined latest revenue of ₹1.64 Cr; the largest is Rsense Healthcare Private Limited at ₹1.30 Cr (FY 2025). Earlier, Suraj Babruwahan Ronge was an Additional Director at Tutelminds Technoconsultants Private Limited (2018).

DIN 06685060
Primary Designation Director
Industry Healthcare
First Appointment 31 Mar 2018
Oldest Company Age 8 yrs
Largest company Rsense Healthcare Private Limited · ₹1.30 Cr (FY 2025)
Combined revenue ₹1.64 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rsense Healthcare Private Limited U85110PN2020PTC196492
Director02 Dec 20202020₹1.30 Cr (FY 2025)Active
Director23 Oct 20182018₹32 Lakh (FY 2024)Active
Director06 Sep 20222022₹2.6 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director31 Mar 20182014₹74.4 Lakh (FY 2017)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rsense Technology Solutions Private Limited
Rsense Healthcare Private Limited
Acic - Sveri Pandharpur Arise Foundation
Tutelminds Technoconsultants Private Limited
Premium access

Shareholding and investment profile for Suraj Babruwahan Ronge

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suraj Babruwahan Ronge

Suraj Babruwahan Ronge currently holds 3 directorships: Rsense Healthcare Private Limited (Director, since 02 Dec 2020, revenue ₹1.30 Cr (FY 2025)); Rsense Technology Solutions Private Limited (Director, since 23 Oct 2018, revenue ₹32 Lakh (FY 2024)); Acic - Sveri Pandharpur Arise Foundation (Director, since 06 Sep 2022, revenue ₹2.6 Lakh (FY 2025)).

Suraj Babruwahan Ronge was first appointed on 31 Mar 2018 as Additional Director at Tutelminds Technoconsultants Private Limited. The most recent appointment on record is 06 Sep 2022 at Acic - Sveri Pandharpur Arise Foundation.

The 3 current companies of Suraj Babruwahan Ronge that report revenue have a combined latest revenue of ₹1.64 Cr: Rsense Healthcare Private Limited ₹1.30 Cr (FY 2025); Rsense Technology Solutions Private Limited ₹32 Lakh (FY 2024); Acic - Sveri Pandharpur Arise Foundation ₹2.6 Lakh (FY 2025).

Suraj Babruwahan Ronge held 1 earlier board appointment: Tutelminds Technoconsultants Private Limited (Additional Director, 31 Mar 2018 to 26 Sep 2018).

The current boards of Suraj Babruwahan Ronge's companies include Babruvahan Pandurang Ronge (Rsense Healthcare Private Limited), Nikhil Hanmant Bagal (Rsense Healthcare Private Limited), Sneha Suraj Ronge (Rsense Healthcare Private Limited), Deepak Kondiba Kandhare (Rsense Technology Solutions Private Limited), Bhimrao Daji Ronge (Acic - Sveri Pandharpur Arise Foundation), Hanmant Mahadeo Bagal (Acic - Sveri Pandharpur Arise Foundation).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available